-
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
Huisman, M. C., Pouw, J. E. E., Golla, S. S. V., Huglo, D., Morschhauser, F., Zijlstra, J. M., Wijngaarden, J. E., Stavenga, M., Sebus, H. J., Slebe, M., Thiele, A., Vugts, D., Miedema, I. H. C., Zwezerijnen, G. J. C., Bahce, I., Menke-van der Houven van Oordt, C. W., Shah, D. K., Jauw, Y. W. S. & Boellaard, R., 1 Dec 2025, In: EJNMMI Research. 15, 1, 122.Research output: Contribution to journal › Article › Academic › peer-review
-
A minimal physiologically-based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti-LAG-3 monoclonal antibody
Michelet, R., Petersson, K., Huisman, M. C., Menke-van der Houven van Oordt, C. W., Miedema, I. H. C., Thiele, A., Montaseri, G., Pérez-Pitarch, A. & Busse, D., 9 Dec 2024, In: CPT: Pharmacometrics and Systems Pharmacology.Research output: Contribution to journal › Article › Academic › peer-review
-
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET
Wijngaarden, J. E., Jauw, Y. W. S., Zwezerijnen, G. J. C., de Wit-van der Veen, B. J., Vugts, D. J., Zijlstra, J. M., van Dongen, G. A. M. S., Boellaard, R., Menke-van der Houven van Oordt, C. W. & Huisman, M. C., 1 Dec 2024, In: EJNMMI Research. 14, 1, 18.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
